Daily news about corporate social responsibility, ethics and sustainability
Tags (2) : HBV
Brii Biosciences Acquires Full Rights to BRII-179 for HBV Cure Advancement
01/01/2025 | Companies
biotechnology,
Brii Biosciences,
BRII-179,
clinical trials,
combination therapies,
drug development,
elebsiran,
ENRICH study,
functional cure,
HBV,
healthcare innovation,
Hepatitis B Virus,
intellectual property acquisition,
know-how,
patents,
PEG-IFNα,
Phase 2b study,
shareholder value,
unmet medical needs,
VBI Vaccines
Companies
Most Popular Now
Environment News
Compliance
Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com